National Heart Institute has distinguished itself as a remarkable centre for adult and pediatric surgeries. Beating heart total arterial coronary artery bypass grafting is now the mainstay of treatment of ischemic heart disease. National Heart Institute is a leader in the treatment of all heart disease for more than 27 years, headed by legend and WCCPC Life time Achievement Awarded Dr. O. P. Yadava. National Heart Institute surgeons have performed more than 15,000 open heart, bypass surgeries for valve repair and replacements and coronary artery bypasses, and more than 10,000 surgeries for diseases of the lungs, esophagus and chest wall.

Our surgeons, along with their extensive clinical, research, and administrative staff, offer comprehensive state of the art therapy for all surgical diseases of the chest including:

• Adult Cardiac Surgery
• Minimally Invasive Cardiac Surgery
• Endoscopic Vein Harvest
• Adult Thoracic Surgery
• Video Assisted Thoracoscopic Surgery
• Pediatric Cardiac and Thoracic Surgery
• Heart Transplantation and Lung Transplantation

National Heart Institute also offer comprehensive state of the art therapy for all surgical diseases of the chest including:

• Coronary Artery Disease
• Minimally Invasive Heart Surgery
• Beating Heart Surgery
• Valvular Diseases Of The Heart
• Aortic Valve Replacement
• Mitral Valve Replacement
• Valves Repair
• Diseases of the Thoracic Aorta
• Aortic Aneurysms
• Aortic Dissections
• Ross Procedure
• Stentless Valvular Procedures
• Aortic Homograft Procedures
• End-Stage Cardiac Disease
• Heart Transplantation
• Lung Cancer
• Emphysema
• Tumors of the Chest Wall, Esophagus And Mediastinum
• Surgery for Hiatal Hernia and Reflux disease (GERD)
• Surgery for Myasthenia Gravis
• Lung Transplantation

Pediatric Cardiology & Cardiac-surgery

In addition, National Heart Institute surgeons offer a complete spectrum of care for pediatric cardiac and thoracic disease including Congenital Heart Disease, Pediatric Thoracic Diseases, End Stage Cardiac Disease, Heart Transplantation, End-Stage Pulmonary Disease and Lung Transplantation.

• Balloon pulmonary valvotomy (BPV)
• Balloon aortic valvuloplasty
• Device closure of ASD, VSD,PDA
• Embolisation of MAPCA

National Heart Institute cardiothoracic surgeons have engaged in a new era of cardiothoracic surgery that promises to significantly improve treatment of the most common forms of heart and lung diseases by introducing minimally invasive technology to cardiothoracic surgery. With the development of the minimally invasive cardiothoracic surgical technology, which includes robotic surgery, National Heart Institute surgeons can achieve results that are safe, precise and reproducible; but with significant benefits to the patient in terms of decreased postoperative pain, recovery time, cost and result.